Pradaxa
These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2010
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9
HUMAN PRESCRIPTION DRUG LABEL
Nov 28, 2023
Boehringer Ingelheim Pharmaceuticals Inc.
DUNS: 603175944
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
dabigatran etexilate mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
dabigatran etexilate mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
dabigatran etexilate mesylate
Product Details
FDA regulatory identification and product classification information